- Home
- JAGX vs GRRRW Comparison
JAGX vs GRRRW Comparison
Compare JAGX & GRRRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAGX
- GRRRW
- Stock Information
- Founded
- JAGX 2013
- GRRRW N/A
- Country
- JAGX United States
- GRRRW United Kingdom
- Employees
- JAGX 49
- GRRRW N/A
- Industry
- JAGX Biotechnology: Pharmaceutical Preparations
- GRRRW Computer Software: Prepackaged Software
- Sector
- JAGX Health Care
- GRRRW Technology
- Exchange
- JAGX Nasdaq
- GRRRW Nasdaq
- Market Cap
- JAGX 3.1M
- GRRRW N/A
- IPO Year
- JAGX N/A
- GRRRW N/A
- Fundamental
- Price
- JAGX $4.85
- GRRRW $0.92
- Analyst Decision
- JAGX
- GRRRW
- Analyst Count
- JAGX 0
- GRRRW 0
- Target Price
- JAGX N/A
- GRRRW N/A
- AVG Volume (30 Days)
- JAGX 37.8K
- GRRRW 336.7K
- Earning Date
- JAGX 03-31-2025
- GRRRW 04-04-2025
- Dividend Yield
- JAGX N/A
- GRRRW N/A
- EPS Growth
- JAGX N/A
- GRRRW N/A
- EPS
- JAGX N/A
- GRRRW 2.28
- Revenue
- JAGX $11,689,000.00
- GRRRW $78,940,347.00
- Revenue This Year
- JAGX $18.18
- GRRRW N/A
- Revenue Next Year
- JAGX $40.06
- GRRRW N/A
- P/E Ratio
- JAGX N/A
- GRRRW $25.04
- Revenue Growth
- JAGX 19.75
- GRRRW 424.97
- 52 Week Low
- JAGX $4.41
- GRRRW $1.06
- 52 Week High
- JAGX $540.00
- GRRRW $1.54
- Technical
- Relative Strength Index (RSI)
- JAGX 20.48
- GRRRW N/A
- Support Level
- JAGX $4.41
- GRRRW N/A
- Resistance Level
- JAGX $5.45
- GRRRW N/A
- Average True Range (ATR)
- JAGX 0.95
- GRRRW 0.00
- MACD
- JAGX 0.00
- GRRRW 0.00
- Stochastic Oscillator
- JAGX 3.54
- GRRRW 0.00
About JAGX Jaguar Health Inc.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.